Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery
Clinical trial NCT01623531 · COMPLETED
Trial details
- NCT number
- NCT01623531
- Sponsor
- Nova Scotia Health Authority
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2019-03-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.